Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,978 | 32,297 | 39,179 | 28,088 | 40,020 |
| Marketable Securities | 214,514 | 404,273 | 133,607 | 148,896 | 87,271 |
| Receivables | 454 | 169 | 176 | 2,058 | 51,090 |
| Inventories | 851 | N/A | N/A | N/A | N/A |
| TOTAL | $269,177 | $441,570 | $174,362 | $181,384 | $179,830 |
| Non-Current Assets | |||||
| PPE Net | 32,269 | 25,160 | 2,154 | 1,536 | 1,210 |
| Investments And Advances | 97,856 | 23,800 | 29,454 | 0 | 7,929 |
| Other Non-Current Assets | 26,350 | 28,369 | 3,113 | 390 | 359 |
| TOTAL | $156,475 | $77,329 | $34,721 | $1,926 | $9,498 |
| Total Assets | $425,652 | $518,899 | $209,083 | $183,310 | $189,328 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,920 | 6,302 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,746 | 12,875 | 1,532 | 966 | 1,400 |
| Accrued Expenses | 26,358 | 19,794 | 19,806 | 12,969 | 8,575 |
| TOTAL | $63,017 | $51,558 | $59,080 | $64,396 | $32,937 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,715 | 18,099 | 19,786 | 19,689 | 4,676 |
| Deferred Revenues | 10,993 | 12,587 | 37,742 | 50,461 | 22,962 |
| Other Non-Current Liabilities | 47,028 | 39,629 | 1,122 | 387 | 251 |
| TOTAL | $76,515 | $81,728 | $84,003 | $104,176 | $77,124 |
| Total Liabilities | $139,532 | $133,286 | $143,083 | $168,572 | $110,061 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,841 | 69,613 | 61,645 | 52,569 | 48,921 |
| Common Shares | 70 | 69 | 60 | 51 | 49 |
| Retained earnings | -617,097 | -485,342 | -429,986 | -374,497 | -289,200 |
| Other shareholders' equity | -499 | 98 | 302 | -214 | -135 |
| TOTAL | $286,120 | $385,613 | $66,000 | $14,738 | $79,267 |
| Total Liabilities And Equity | $425,652 | $518,899 | $209,083 | $183,310 | $189,328 |